Musings on genome medicine: the Obama effect redux.
From the point of view of genome medicine, Barack Obama has made two vital policy decisions: he has chosen a new director of the National Institutes of Health, and his proposed change in United States healthcare policy will have profound effects on genome medicine and, indeed, all of academic medicine.
Nathan
David G
DG
Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA,. david_nathan@dfci.harvard.edu.
Orkin
Stuart H
SH